Adjusted CHAT-AD for Alzheimer Disease
Study Summary
The purpose of this study is to see whether an adapted questionnaire called the Care Partner Hospital Assessment Tool (CHAT) for care partners of hospitalized patients living with Alzheimer's disease and related dementias (ADRD) (CHAT-AD) can help people with dementia receive better care after they go home from the hospital. Participants will be a care partner ('family member or friend') who provides unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of dementia. Participants can expect to be in this study for 14 days.
- Alzheimer Disease
- Dementia
Treatment Effectiveness
Study Objectives
2 Primary · 6 Secondary · Reporting Duration: 72 hours post-discharge
Trial Safety
Trial Design
2 Treatment Groups
Standard of Care
1 of 2
Adjusted CHAT-AD
1 of 2
Active Control
Experimental Treatment
128 Total Participants · 2 Treatment Groups
Primary Treatment: Adjusted CHAT-AD · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 26th, 2021
Last Reviewed: November 8th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.